Besibac Ophthalmic Solution 0.6% is an antibiotic belonging to the class of fluoroquinolone. It is used to treat bacterial infections of the eyes, nose, and throat.
Besibac Ophthalmic Solution 0.6% is used to treat bacterial conjunctivitis, bacterial keratitis, bacterial rhinitis, and bacterial pharyngitis.
| Brand Name | Besibac |
|---|---|
| Type | Ophthalmic Solution |
| Weight | 0.6% |
| Generic | Besifloxacin |
| Manufacturer | Popular Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Besibac Ophthalmic Solution 0.6% exerts its antimicrobial action by inhibiting the enzymes, DNA gyrase and topoisomerase IV, which are essential for the bacterial DNA replication, transcription, and repair. This results in the inhibition of the growth and multiplication of the bacteria.
Besibac Ophthalmic Solution 0.6% may start to work within 24 hours of administration. A full course of therapy, as prescribed by the doctor, is necessary for the complete resolution of the infection.
The bioavailability of Besibac Ophthalmic Solution 0.6% is approximately 77%. It is rapidly absorbed from the ocular surface and is present in the ocular tissues for up to 12 hours.
Besibac Ophthalmic Solution 0.6% is eliminated through the kidneys by glomerular filtration.
The recommended dosage of Besibac Ophthalmic Solution 0.6% is as follows:
Besibac Ophthalmic Solution 0.6% is available in two forms: ophthalmic solution and oral suspension. The ophthalmic solution is used for ocular infections and the oral suspension is used for respiratory infections.
The common side effects of Besibac Ophthalmic Solution 0.6% include eye irritation, headache, dizziness, and nausea. Other rare side effects include allergic reactions, palpitations, tachycardia, and gastrointestinal upset.
Besibac Ophthalmic Solution 0.6% has low toxicity and most of the side effects are mild and reversible. In case of severe side effects, the medication should be discontinued and the patient should seek medical help.
Besibac Ophthalmic Solution 0.6% should be used with caution in patients with known hypersensitivity to quinolones. It should be avoided in patients with a history of myasthenia gravis due to the risk of worsening of the symptoms. It should be used with caution in patients with a history of epilepsy or other seizure disorders, as it may increase the frequency of seizures.
Besibac Ophthalmic Solution 0.6% has the potential to interact with other medications. It should not be used in combination with any other quinolones or antacids containing magnesium, aluminum, or iron, as it may decrease its absorption. It should also be used with caution in combination with other medications such as anticoagulants, antiplatelet agents, immunosuppressants, and antidiabetics.
Besibac Ophthalmic Solution 0.6% should be used with caution in patients with known hypersensitivity to quinolones, myasthenia gravis, epilepsy, and other seizure disorders, kidney or liver disease, and diabetes.
Besibac Ophthalmic Solution 0.6% should not be used in combination with other quinolones or antacids containing magnesium, aluminum, or iron, as it may decrease its absorption. It should also not be used in combination with anticoagulants, antiplatelet agents, immunosuppressants, and antidiabetics.
Besibac Ophthalmic Solution 0.6% should be taken at least two hours before or six hours after the consumption of food, dairy products, antacids, vitamins, and iron supplements to reduce the risk of interaction.
Besibac Ophthalmic Solution 0.6% should not be used during pregnancy, unless absolutely necessary. It is not known if it is safe for use during breastfeeding.
Besibac Ophthalmic Solution 0.6% should not be used during breastfeeding, as it may pass into breast milk and harm the nursing infant.
In cases of accidental overdose, supportive measures such as gastric lavage and symptomatic management should be given. The patient should be closely monitored for signs of toxicity and side effects.
Besibac Ophthalmic Solution 0.6% is contraindicated in patients with known hypersensitivity to quinolones, myasthenia gravis, epilepsy, and other seizure disorders.
Besibac Ophthalmic Solution 0.6% should be administered exactly as prescribed by the doctor. The medication should be used at regular intervals and for the full duration of the prescribed therapy. Dosage should not be increased without consulting the doctor.
Besibac Ophthalmic Solution 0.6% should be stored at room temperature in a cool, dry place. The ophthalmic solution should be kept in its original container and should not be exposed to direct sunlight or heat.
The volume of distribution of Besibac Ophthalmic Solution 0.6% is 14.3 L.
The half-life of Besibac Ophthalmic Solution 0.6% is 4 hours.
The clearance of Besibac Ophthalmic Solution 0.6% is 8.1 mL/min.
See in details version Besibac Ophthalmic Solution 0.6% also Besibac Ophthalmic Solution 0.6% in bangla
Prof. Dr. Kazi A. Karim
Skin, Allergy, Leprosy, Sex Diseases Specialist & Dermato Surgeon